Clinical Endpoints is a clinical research site located in Scottsdale, Arizona, United States 85258.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
Clinical Endpoints has participated in 6 clinical trials with 2 currently active.
Therapeutic areas: Alzheimer Disease, Early Alzheimers Disease, Relapsing Remitting Multiple Sclerosis.
Sponsors: Acumen Pharmaceuticals, Ono Pharmaceutical Co. Ltd, Annovis Bio Inc..
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Clinical Endpoints has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Clinical Endpoints has 6 clinical trials on record, with 2 currently active. Their work covers Alzheimer Disease, Early Alzheimers Disease, Relapsing Remitting Multiple Sclerosis.
Clinical Endpoints has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.